Inventor · disambiguated record
Ke Liu
Also filed as: LIU KE · LIU KE J · LIU KE JIAN JIM · LIU KE-JIAN
54 granted patents·27 pending applications·472 citations·filing 1993–2025
98Inventor score
Files withACCUTAR BIOTECHNOLOGY INC28ECOLE POLYTECHNIQUE FED LAUSANNE EPFL6XENCOR INC6STC UNM5TIGER BIOTHERAPEUTICS INC4
Top patents by PatentIndex Score
81 records- 0197US11420956B2Ureas having Androgen Receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Aug 23, 2022·6 cites·21 claims
- 0297US10800770B1Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Oct 13, 2020·9 cites·22 claims
- 0396US11358999B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2019·Granted Jun 14, 2022·12 cites·2 claims
- 0496US11312702B2Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 26, 2022·4 cites·20 claims
- 0596US9044451B2Use of delta tocopherol for the treatment of lysosomal storage disordersZHENG WEI·Filed 2011·Granted Jun 2, 2015·36 cites·18 claims
- 0695US11655277B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2022·Granted May 23, 2023·2 cites·1 claims
- 0795US11535606B2Substituted quinoline-8-carbonitrile derivatives with androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Dec 27, 2022·4 cites·34 claims
- 0895US11261178B2Chroman derivatives having estrogen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Mar 1, 2022·5 cites·9 claims
- 0995US10836749B1Substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Nov 17, 2020·3 cites·25 claims
- 1094US11851466B2Targeted IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2020·Granted Dec 26, 2023·3 cites·16 claims
- 1194US10364507B2Nanopore forming method and uses thereofECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2017·Granted Jul 30, 2019·9 cites·17 claims
- 1293US11220490B2Ureas having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2021·Granted Jan 11, 2022·2 cites·10 claims
- 1390US11618776B2Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domainsXENCOR INC·Filed 2019·Granted Apr 4, 2023·4 cites·7 claims
- 1487US11401625B2Nanopore forming method and uses thereofECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2021·Granted Aug 2, 2022·1 cites·18 claims
- 1585US9944632B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2017·Granted Apr 17, 2018·3 cites·12 claims
- 1683US10923214B2Neural network for predicting drug propertyACCUTAR BIOTECHNOLOGY INC·Filed 2018·Granted Feb 16, 2021·8 cites·20 claims
- 1780US10696659B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2019·Granted Jun 30, 2020·2 cites·30 claims
- 1879US12234270B2IL-12 heterodimeric Fc-fusion proteinsXENCOR INC·Filed 2022·Granted Feb 25, 2025·0 cites·2 claims
- 1979US12195459B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Granted Jan 14, 2025·0 cites·46 claims
- 2079US12110291B2Glutarimide-containing pan-KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·32 claims
- 2179US7381405B2Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancerUS HEALTH·Filed 2002·Granted Jun 3, 2008·6 cites·13 claims
- 2279US2023374693A1Nanopore forming method and uses thereofECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2023·Application pending·0 cites
- 2378US10947637B2Nanopore forming method and uses thereofECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2019·Granted Mar 16, 2021·1 cites·16 claims
- 2478US9120810B2Compounds and methods for the treatment of isocitrate dehydrogenase related diseasesBROAD INST INC·Filed 2013·Granted Sep 1, 2015·2 cites·47 claims
- 2577US12448423B2Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domainsXENCOR INC·Filed 2022·Granted Oct 21, 2025·0 cites·14 claims
- 2677US10550103B2Dual inhibitors of PARP1 and CDKAccutar Biotechnology·Filed 2019·Granted Feb 4, 2020·1 cites·29 claims
- 2777US10519136B2Dual inhibitors of PARP1 and CDKAccutar Biotechnology·Filed 2018·Granted Dec 31, 2019·1 cites·31 claims
- 2877US2025092039A1Glutarimide-containing pan-kras-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2976US11753738B2Nanopore forming method and uses thereofECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2022·Granted Sep 12, 2023·0 cites·16 claims
- 3075US5494030AApparatus and methodology for determining oxygen in biological systemsDARTMOUTH COLLEGE·Filed 1993·Granted Feb 27, 1996·189 cites·18 claims
- 3175US2023135173A1Novel substituted quinoline-8-carbonitrile derivatives having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 3274US9606129B2Blood biomarker for early blood brain barrier disruption in ischemic strokeSTC UNM·Filed 2015·Granted Mar 28, 2017·1 cites·4 claims
- 3374US2023150973A1Novel ureas having androgen receptor degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 3473US11521712B2Computational method for classifying and predicting ligand docking conformationsACCUTAR BIOTECHNOLOGY INC·Filed 2018·Granted Dec 6, 2022·3 cites·24 claims
- 3573US2024425519A1Novel spirocyclic compounds as klhdc2 ligandsUNIV WASHINGTON·Filed 2022·Application pending·0 cites
- 3671US2025382236A1Oxygenating and rooting water-soluble fertilizer compounded with biostimulant and preparation method thereforSHANDONG BAINONG SIDA BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 3770US12168058B2Glutarimide-containing KRAS-mutant degrader compounds and uses thereofTIGER BIOTHERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·0 cites·47 claims
- 3870US10968212B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2019·Granted Apr 6, 2021·0 cites·48 claims
- 3970US10591491B1Blood biomarker for early blood brain barrier disruption in ischemic strokeSTC UNM·Filed 2019·Granted Mar 17, 2020·0 cites·2 claims
- 4069US12338248B2Aminopyrimidine derivatives as cyclin-dependent kinase inhibitorsACCUTAR BIOTECHNOLOGY INC·Filed 2024·Granted Jun 24, 2025·0 cites·48 claims
- 4168US10450307B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2018·Granted Oct 22, 2019·0 cites·17 claims
- 4268US2023132378A9Compositions and methods for treating hemorrhagic strokeUNM RAINFOREST INNOVATIONS·Filed 2022·Application pending·0 cites
- 4367US9599625B2Blood biomarker for early blood brain barrier disruption in ischemic strokeLIU KE JIAN·Filed 2014·Granted Mar 21, 2017·1 cites·1 claims
- 4467US2024317777A1Novel macrocyclic aminopyrazole compounds as cdk2 inhibitorsACCUTAR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 4565US11117885B2Compounds having estrogen receptor alpha degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2020·Granted Sep 14, 2021·0 cites·18 claims
- 4665US2024208909A1Substituted quinoline derivatives having sos1 inhibition activities and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 4765US2024190842A1Substituted quinolinone-8-carbonitrile derivatives having androgen degradation activity and uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 4865US2025002473A1Quinoxaline derived sulfonamides with egfr degradation activities and their uses thereofACCUTAR BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 4964US10254295B2Blood biomarker for early blood brain barrier disruption in ischemic strokeSTC UNM·Filed 2017·Granted Apr 9, 2019·0 cites·7 claims
- 5064US10179933B2Hybrid nanopores and uses thereof for detection of analytesYISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD·Filed 2014·Granted Jan 15, 2019·0 cites·12 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →